- ONS Bridge (https://voice.ons.org/conferences/ons-bridge)
- Access to Cancer Care (https://voice.ons.org/topic/access-to-cancer-care)
- Patient financial advocacy (https://voice.ons.org/topic/patient-financial-advocacy)
- Patient assistance programs (https://voice.ons.org/topic/patient-assistance-programs)
Mylan Patient Specialists Help Support Patients Through Biosimilar Cancer Treatments
Mylan understands that you care about your patients and that this may be a difficult time for them. Now more than ever, additional treatment options, such as biosimilars offerings may play an important role in providing patients access to medications they need.
To help your patients gain access to biosimilar medications, we created a patient support services program for Mylan's biosimilar products, available through Mylan Advocate®.
Mylan Advocate includes a team of dedicated patient specialists available to help support your patients. Reach Mylan Advocate specialists by phone Monday–Friday, 9 am–8 pm ET, at 833-695-2623. View a full list of our offerings at mylanadvocateportal.com (http://www.mylanadvocateportal.com/), which include:
- Benefits verification
- Alternate funding support
- Copay assistance program for eligible patients
In addition to the patient services, Mylan has some helpful videos regarding integrating a HER2+ biosimilar into clinical practice, accessible at treatmentperspectives.com/her2/mylan (https://www.treatmentperspectives.com/her2/mylan)
For nearly 60 years, Mylan has focused on providing access to treatments to all patients around the globe. Mylan has a long history of making complex products, with one of the largest and most diverse global portfolios, including 20 biosimilars and insulin analogs in development or on the market. With 10 manufacturing sites focusing on biosimilar product development, Mylan has the capacity to supply the market and customer needs, even in the midst of a global pandemic.
Mylan Advocate is registered trademark of Mylan Pharmaceuticals Inc. MYLAN is a registered trademark of Mylan Inc.
©2020 Mylan N.V. All Rights Reserved.